Oncologists
Bring the case and the clinical question, and translate findings into a plan.
Personalized multi-omics tumor board
Research-grade bioinformatics for the hardest cancer cases.
Ometorium convenes oncologists and computational biologists around a single patient — pairing deep multi-omics analysis with clinical judgment to surface options a standard tumor board can't reach.
WES · RNA-seq · proteomics · single-cell · spatial
Whole-exomeRNA-seqProteomicsSingle-cellSpatialMethylation
The approach
Everything meaningful happens where multi-omics meets the clinic.
We analyze a patient's tumor across every available layer, then bring the findings to a board that decides what to do about them — research-grade depth, translated into a clinical recommendation.
Explore the platform
How it works
From a difficult case to a decision.
01Oncologist
Submit a case
An oncologist brings the patient's diagnosis and a brief summary of the question that needs answering.
02Coordinator
Assemble the board
Oncologists and computational biologists are matched to the case and confirm their part.
03Researcher & oncologist
Gather data & records
Sequencing, multi-omics, and medical records are logged and linked — externally hosted, access tracked.
04The board
Convene the meeting
An in-depth, up-to-two-hour board reviews each research report and works the case together.
05Board lead
Record the recommendation
The consortium agrees on next steps and documents a recommendation for the patient's care.
Depth for one patient
The rigor of a research lab, focused on a single case.
Ometorium is built for N-of-1 work — integrating whole-exome, transcriptomic, proteomic, single-cell and spatial data into one interpretation, so the board sees the whole biology of the tumor, not a fragment of it.
Who's at the tableN-of-1Built for the single patient
6Omics layers integrated
2 hrsEvery board runs deep
100%Your data stays yours
Our founding principle
"Every patient facing a hard cancer deserves the depth of a research lab and the judgment of a full board — brought together for their case alone."
The Ometorium missionPersonalized multi-omics tumor boards
Who's at the table
A board built from four perspectives.
01
02
Computational biologists
Turn raw sequencing and multi-omics data into research-grade interpretation.
03
Coordinators
Assemble the right team, track materials, and keep the board on time.
04
Patients & caregivers
Take part in their own case, see progress, and share what matters to them.
Common questions
What is a personalized multi-omics tumor board?
A molecular tumor board taken further — instead of reviewing a single genomic report, the board integrates multiple layers of a patient's tumor biology and brings research-grade analysis to the discussion.
How is this different from a standard tumor board?
Standard boards work from routine testing. Ometorium pairs each case with computational biologists who analyze whole-exome, RNA-seq, proteomic, single-cell and spatial data, then present it for the board to act on.
Who is it for?
Patients with challenging or advanced cancers, and the oncologists seeking additional options for them.
What data do you need?
At minimum, raw whole-exome and RNA sequencing plus core medical records. Additional layers — proteomics, single-cell, spatial — deepen the analysis. Files stay hosted with you; the workspace records what exists and who to contact for access.